Company

Lineagen

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

ADVANCING THE WAY YOU SEE THE GENOME

Also known as Bionano Genomics, Inc., Bionano Laboratories

Medical devices & diagnostics

Status: Acquiredas of 2026-09-19Source (opens in a new tab)
Business model: B2B
Founded: 2006
Customers: health care providers, researchers, and industry partners
Legal name: Bionano Genomics, Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

We provide access to the genetic answers and support you need through cutting-edge genetic analysis across medicine and research.

Funding snapshot

Total raised: $238MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $20M2024-07-08

Funding rounds

Round, 2024: $20M2024-07-08, SEC form D sold, 2 investors
Round, 2024: $20M2024-05-24, SEC form D sold, 4 investors
Round, 2023: $35M2023-10-13, SEC form D sold, 1 investor
Round, 2021: $41.9M2021-10-18, SEC form D sold, 27 investors
Round, 2019: $2.5M2019-03-14, SEC form D sold, 3 investors
Round, 2014: $68.4M2014-09-09, SEC form D sold, 17 investors
Round, 2014: $5M2014-06-12, SEC form D sold, 5 investors
Round, 2013: $15K2013-12-11, SEC form D sold, 1 investor
Round, 2013: $10M2013-09-17, SEC form D sold, 5 investors
Round, 2012: $11.6M2012-06-20, SEC form D sold, 6 investors
Round, 2011: $23.3M2011-03-15, SEC form D sold, 9 investors
Round, 2010: $782K2010-04-14, SEC form D sold, 3 investors

About the company

Status notes: Acquired by Bionano Genomics in 2020

Products

Other: Clinical Services
Other: OGM Services

Exit

Acquisition: 2020